Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma

doi:10.3748/wjg.v16.i28.3521

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5398)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

454

HTML

4616

Figures (1-7)

328

Sum=5398

Jul 28, 2010 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jul 28, 2010; 16(28): 3521-3528
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3521

Full Size Figure Download Figure

Figure 6 Serum glypican-3 levels. Serum glypican-3 (GPC3) levels were measured using a commercially available sandwich ELISA kit. Bar: Standard error. Serum GPC3 levels were significantly higher in patients with hepatocellular carcinoma (HCC) than in non-HCC subjects (P < 0.05). HBV: Hepatitis B virus.

Citation: Akutsu N, Yamamoto H, Sasaki S, Taniguchi H, Arimura Y, Imai K, Shinomura Y. Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma. World J Gastroenterol 2010; 16(28): 3521-3528
URL: https://www.wjgnet.com/1007-9327/full/v16/i28/3521.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i28.3521